Product Reports Resources Pricing Login Book a demo

Tasso

Health Tech & Medtech · Seattle, United States · Founded 2012

Tasso Inc. is a healthcare technology company that specializes in patient-centric devices for remote blood sample collection. The company operates in the clinical trial market, providing a convenient and virtually painless solution for blood collection that can be done anytime, anywhere. This is particularly beneficial for decentralized clinical trials, where patients are not required to visit a specific location for their tests. Tasso's business model revolves around its innovative blood collection devices. These devices are digitally-enhanced, making them easy to use and less painful than traditional methods of blood collection. They are designed to improve patient experience, which can help drive patient recruitment and retention in clinical trials. The company also offers solutions for population pharmacokinetics (PopPK), a method used in clinical trials to study how a drug is processed in the body. By enhancing data density and fidelity, Tasso's solutions can improve the accuracy and reliability of these studies. In addition to selling devices, Tasso also provides an integrated logistics platform. This supports shipping, participant engagement, and other aspects of running a decentralized clinical trial. This means that Tasso not only makes money from selling its devices, but also from providing services that help clinical trials run smoothly. In summary, Tasso Inc. is a healthcare technology company that provides easy-to-use, painless blood collection devices and services for decentralized clinical trials. Its innovative solutions are designed to improve patient experience and enhance the accuracy and reliability of clinical trials. Keywords: Healthcare technology, Patient-centric devices, Remote blood sample collection, Decentralized clinical trials, Population pharmacokinetics, Digitally-enhanced devices, Patient recruitment and retention, Integrated logistics platform, Clinical-grade blood samples, Convenience in healthcare.

Investors

14 investors on Tasso's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
MedTech Innovator
Series A 13 investors entered at this stage
Vertical Venture Partners
Techstars
Foresite Capital
Merck Global Health Innovation Fund
Cedars-Sinai
RA Capital Management
D.E. Shaw Group
Senvest Capital
J2 Ventures
Incube
Hambrecht Ducera Growth Ventures
SVB Innovation Fund
Merck GHIF

Global footprint

Where Tasso has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States98.4%
🇲🇽 Mexico1.6%
2 countries shown

Talent graph

The shape of Tasso's talent

Dealroom maps Tasso's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

14 team members profilednamed & role-tagged by Dealroom
101 employeestotal headcount
4 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Tasso's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Tasso

An AI-synthesized read of the highest-engagement posts about Tasso on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tasso on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.